< Back to previous page
Researcher
Getahun Befirdu Abza
- Disciplines:Pharmacokinetics
Affiliations
- Drug Delivery and Disposition (Division)
Member
From1 Mar 2019 → Today
Projects
1 - 1 of 1
- Pharmacokinetic boosting approach for tyrosine kinase inhibitors – Sorafenib and Lenvatinib – targeting hepatocellular carcinomaFrom1 Mar 2019 → 1 Mar 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 3 of 3
- Unravelling the Hepatic Elimination Mechanisms of Colistin(2023)
Authors: Matthias Gijsen, Tom De Vocht, Getahun Befirdu Abza, Nina Nauwelaerts, Joost Wauters, Pieter Annaert
Pages: 1723 - 1734 - Clinicopathological Features and Survival of Patients with Hepatocellular Carcinoma in Ethiopia: A Multicenter Study(2023)
Authors: Getahun Befirdu Abza, Pieter Annaert
- Quantitative determination of colistin A/B and colistin methanesulfonate in biological samples using hydrophilic interaction chromatography tandem mass spectrometry(2020)
Authors: Bing Qi, Matthias Gijsen, Pieter Van Brantegem, Tom De Vocht, Neel Deferm, Getahun Befirdu Abza, Nina Nauwelaerts, Joost Wauters, Isabel Spriet, Pieter Annaert
Pages: 1183 - 1195